Showing results (181-190 of 194) with videos related to

Sort By:
Pageof 20
Nature Communications|October 31, 2024
Risk-stratified treatment for drug-susceptible pulmonary tuberculosisVincent K Chang, Marjorie Z Imperial, Patrick P J Phillips, et al.
Lancet (London, England)|December 14, 2020
Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority studyEdgar T Overton, Gary Richmond, Giuliano Rizzardini, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 4, 2019
Feasibility of Identifying Household Contacts of Rifampin-and Multidrug-resistant Tuberculosis Cases at High Risk of Progression to Tuberculosis DiseaseAmita Gupta, Susan Swindells, Soyeon Kim, et al.
The New England Journal of Medicine|October 21, 2011
Timing of antiretroviral therapy for HIV-1 infection and tuberculosisDiane V Havlir, Michelle A Kendall, Prudence Ive, et al.
American Journal of Respiratory and Critical Care Medicine|February 15, 2023
A Standardized Approach for Collection of Objective Data to Support Outcome Determination for Late-Phase Tuberculosis Clinical TrialsEkaterina V Kurbatova, Patrick P J Phillips, Susan E Dorman, et al.
The New England Journal of Medicine|May 5, 2021
Four-Month Rifapentine Regimens with or without Moxifloxacin for TuberculosisSusan E Dorman, Payam Nahid, Ekaterina V Kurbatova, et al.
The Lancet. Infectious Diseases|March 8, 2014
Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trialBeatriz Grinsztejn, Mina C Hosseinipour, Heather J Ribaudo, et al.
Medicine|February 13, 2016
The F4/AS01B HIV-1 Vaccine Candidate Is Safe and Immunogenic, But Does Not Show Viral Efficacy in Antiretroviral Therapy-Naive, HIV-1-Infected Adults: A Randomized Controlled TrialWarren Dinges, Pierre-Marie Girard, Daniel Podzamczer, et al.
The New England Journal of Medicine|July 20, 2011
Prevention of HIV-1 infection with early antiretroviral therapyMyron S Cohen, Ying Q Chen, Marybeth McCauley, et al.
The New England Journal of Medicine|July 19, 2016
Antiretroviral Therapy for the Prevention of HIV-1 TransmissionMyron S Cohen, Ying Q Chen, Marybeth McCauley, et al.
Pageof 20